Additional file 1 of Trends in cardiovascular risk factor prevalence, treatment, and control among US adolescents aged 12 to 19 years, 2001 to March 2020
Creators: name: Qu, Qiang
name: Guo, Qixin
name: Shi, Jinjing
name: Chen, Ziqi
name: Sun, Jinyu
name: Cheang, Iokfai
name: Gao, Rongrong
name: Zhou, Yanli
name: Zhang, Haifeng
name: Liao, Shengen
name: Yao, Wenming
name: Li, Xinli
Publisher: name: figshare
Year: 2024
Subjects: subject: Biotechnology
subject: Chemical Sciences not elsewhere classified
subject: Immunology
subject: FOS: Clinical medicine
subject: Biological Sciences not elsewhere classified
subject: Developmental Biology
subject: Marine Biology
subject: Science Policy

description: Additional file 1: eMethod 1. Therapeutic Drug Classes Used to Define Any Use of Antihypertensive and Antidiabetic Medications. eFigure 1. Inclusion Diagram for US Adolescents Aged 12 to 19 Years, 2001 to March 2020. eFigure 2. Age-Adjusted Trends in Mean BP, Hemoglobin A1c, FPG, TC, HDL-C, Non-HDL-C, LDL-C, Triglycerides Levels, Body Mass Index, Weekly Exercise Time, and HEI-2015 for US Adolescents Aged 12 to 19 Years, 2001 to March 2020. eFigure 3. Age-Adjusted Trends in Mean BP, Hemoglobin A1c, FPG, TC, HDL-C, Non-HDL-C, LDL-C, Triglycerides Levels, Body Mass Index, Weekly Exercise Time, and HEI-2015 for US Adolescents Aged 12 to 19 Years by Sex, 2001 to March 2020. eFigure 4. Age-Adjusted Trends in Mean BP, Hemoglobin A1c, FPG, TC, HDL-C, Non-HDL-C, LDL-C, Triglycerides Levels, Body Mass Index, Weekly Exercise Time, and HEI-2015 for US Adolescents Aged 12 to 19 Years by Race/Ethnicity, 2001 to March 2020. eFigure 5. Age-Adjusted Trends in the Prevalence of Hypertension, Elevated BP, Diabetes, Prediabetes, Hyperlipidemia, Obesity, Overweight, Cigarette Use, Inactive Physical Activity, and Poor Diet Quality Among US Adolescents Aged 12 to 19 Years by Sex, 2001 to March 2020. eFigure 6. Age-Adjusted Trends in the Prevalence of Hypertension, Elevated BP, Diabetes, Prediabetes, Hyperlipidemia, Obesity, Overweight, Cigarette Use, Inactive Physical Activity, and Poor Diet Quality Among US Adolescents Aged 12 to 19 Years by Race/Ethnicity, 2001 to March 2020. Years by Race/Ethnicity, 2001 to March 2020. eFigure 7. Age-Adjusted Trends in the Prevalence of High BP and Hypertension Treatment and Control Rates Among US Adolescents Aged 12 to 19 Years According to the 2003 NIH/NHLBI and 2004 NIH/NHLBI Guidelines, 2001 to March 2020. eTable 1. Unweighted Response Rates for the NHANES In-Home Interviews and Mobile Examinations Among US Adolescents Aged 12 to 19 Years by Age and Sex Groups, 2001 to March 2020. eTable 2. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Reporting Guideline for Reporting Cross-sectional Studies Checklist. eTable 3. Classification of BP by the 2003 NIH/NHLBI, 2004 NIH/NHLBI, 2017 AAP, and 2017 ACC/AHA Guidelines. eTable 4. Trends in Age-Adjusted Means or % (95% CIs) of Cardiovascular Parameters, Cardiovascular Risk Factors, and Hypertension and Diabetes Treatment and Control Among US Adolescents Aged 12 to 19 Years by Age and Racial/Ethnic Groups, 2001 to March 2020. eTable 5. Age-Adjusted Rates of Hypertension and Diabetes Treatment and Control by Subgroups Among US Adolescents Aged 12 to 19 Years, 2001 to March 2020. eTable 6. Adjusted ORs for Hypertension and Diabetes Treatment and Control by Subgroups Among US Adolescents Aged 12 to 19 Years, 2001 to March 2020. eTable 7. Comparison of Baseline Characteristics Between the Included and Excluded Study Population. eTable 8. Baseline Characteristics of the Excluded Study Population, 2001 to March 2020.